Pharmacokinetic-Pharmacodynamic modeling of the antibiotic effect of piperacillin in vitro

Pharmaceutical Research

Volumn 13, Issue 1, 1996, Pages 91-96

  Nolting, Arno ^a   Dalla Costa, Teresa ^a   Rand, Kenneth H ^b   Derendorf, Hartmut ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

E(max) model; Escherichia coli; Piperacillin; PK PD modeling

Indexed keywords

BETA LACTAM ANTIBIOTIC; PIPERACILLIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; ESCHERICHIA COLI; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SIMULATION;

COMPUTER SIMULATION; DRUG EVALUATION, PRECLINICAL; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; PENICILLINS; PIPERACILLIN; REGRESSION ANALYSIS;

EID: 0029967445     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016085402278     Document Type: Article

References (18)

1. S.C. Ebert. Pharmacokinetic-pharmacodynamic modeling of irreversible drug effects. In H. Derendorf, G. Hochhaus (eds.), Handbook of Pharmacokinetic-pharmacodynamic Correlation. CRC Press, Boca Raton, pp. 35-56 (1995).
2. A. Nolting and H. Derendorf. Pharmacokinetic-pharmacodynamic modeling of antibiotics. In H. Derendorf, G. Hochhaus (eds.), Handbook of Pharmacokinetic-pharmacodynamic Correlation. CRC Press, Boca Raton, pp. 363-88 (1995).
3. J. Zhi, C.H. Nightingale and, R. Quintiliani. Microbial pharmacodynamics of piperacillin in neutropenic mice of systematic infection due to Pseudomonas aeruginosa. J. Pharmacokin. Biopharm. 16: 355-75 (1988).
4. H. Mattie. A mathematical description of short-term effects of β-lactam antibiotics on bacterial growth in vitro, Cur. Microb. 1: 105-9 (1978).
5. H. Mattie and G. B. van der Voet. Influence of aminopenicillins on bacterial growth kinetics in vitro in comparison with the antibacterial effect in vivo. Infection 7: S434-S437 (1979).
6. G. B. van der Voet, H. Mattie, and R. van Furth. Comparison of the antibacterial activity of azlocillin and ticarcillin in vitro and in irradiated neutropenic mice. J. Antimicrob. Chemother. 16: 605-13 (1985).
7. M. W. Kunst and H. Mattie. Cefazolin and cephadrine: relationship between antibacterial activity in vitro and in mice experimentally infected with Escherichia coli. J. Infect. Dis. 137: 391-402 (1978).
8. T. Bergan, I. B. Carlsen, and J. E. Fugelsang. An in vitro model for monitoring bacterial responses to antibiotic agents under simulated in vivo conditions. Infection 8: S96-S102 (1980).
9. J. Blaser, B. B. Stone, and S. H. Zinner. Two compartment kinetic model with multiple artificial capillary units. J. Antimicrob. Chemother. 15(Suppl A): 131-7 (1985).
10. J. Blaser, B. B. Stone, M. C. Groner, and S. H. Zinner. Impact of netilmicin regimens on the activities of ceftazidime-netilmicin combinations against Pseudomonas aeruginosa in an in vitro pharmacokinetic model. Antimicrob. Agents Chemother. 28: 64-8 (1985).
11. L. D. Thrupp. Susceptibility testing of antibitotics in liquid media. In V. Lorian (ed.), Antibiotics in Laboratory Medicine, pp. 73-113. The Williams & Wilkins Co., Baltimore (1980).
12. R.J. Fass and R.B. Prior. Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate. Antimicrob. Agents Chemother. 33:1268-74 (1989).
13. SCIENTIST User Handbook, Version 2.0, MicroMath Scientific Software, Salt Lake City, UT84121, p. 467 (1995).
14. H. Derendorf, G. Hochhaus, H. Möllmann, J. Barth, M. Krieg, S. Tunn, and C. Möllmann. Receptor-based pharmacokinetic-pharmacodynamic analysis of corticosteroids. J. Clin. Pharmacol., 33: 115-123 (1993).
15. H. Derendorf. Pharmacokinetic evaluation of β-lactam antibiotics. J. Antimicrob. Chem., 24: 407-413 (1989).
16. A. Nolting, T. Dalla Costa, R. Vistelle, K. Rand and H. Derendorf. Determination of free tissue concentrations of piperacillin by microdialysis. J. Pharm. Sci., submitted for publication.
17. T. Bergan and J. D. Williams. Dose dependence of piperacillin pharmacokinetics. Chemotherapy, 28:153-59 (1982).
18. V.K. Batra, J.A. Morrison, K.C. Lassater and V.A. Joy. Piperacillin kinetics. Clin. Pharm. Ther. 26:41-53 (1979).